The French company Device-ALab, specialist in infrared camera cores, joins the Photonis group
Device-ALab, a company specializing in infrared camera cores, joined the Photonis group on Friday March 5th. This transaction allows Device-ALab to benefit from the strategic, commercial and operational support of the Photonis group. Device-ALab's activity confirms Photonis's desire to expand into new commercial markets and to diversify its product offering.
Device-ALab's know-how is focused on infrared imaging, very high speed data conversion, analog sensor electronics, interfaces and communication protocols in imaging.
The markets and applications using Device-ALab technology are as varied as the markets where Photonis has a presence: defense, smart cities (urban traffic control, presence control in buildings), security (firefighters, police, health (tumor detection), industry, industrial inspection, drones and leisure, etc.
Device-ALab and Photonis, partner companies for several years, are already collaborating on joint projects of fusion between thermal and digital image intensification (I²). They also share the same values as innovation through R&D, development through export, service to our Forces.
The acquisition of Device-ALab know-how had therefore become obvious to Photonis.
About Device-ALab:
2020 turnover: € 2.7M; number of employees: 18 (end of 2020)
Device-ALab was incorporated in 2010 as a spin-off of E2V semiconductors based inSaint-Egrève (38). The team knowledge roots in decades at Thomson-TCS, Atmel & E2V in development of electronic subsystems for Imaging (industrial cameras, X-ray sensors) and Data Conversion (DAC-ADC development kits). Since 2017, the company has successfully undergone a strategic transformation from an engineering company to a core-camera product company with remarkable growth.
Related content
FROM Oct 08th 2024 TO Oct 10th 2024
Visit Exosens at VISION 2024 - Booth 8C26, Hall 8 in Stuttgart. VISION 2024 is the world’s leading exhibition for machine vision technologies and system integrators.
Financial press release
Jul 24th 2024
Exosens (Euronext FR001400Q9V2 – EXENS), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology components, achieved consolidated revenue of €186.9 million for the first half 2024.
Financial press release
Jul 08th 2024
EXOSENS S.A. (Euronext Paris: FR001400Q9V2) announces today the implementation of a liquidity agreement with Kepler Cheuvreux to enhance the liquidity of EXOSENS shares admitted to trading on Euronext Paris....
article
Jun 28th 2024
Photonis contributes cutting-edge technology to svom mission, advancing our understanding of gamma-ray bursts
Event
Moscone Center, San Francisco, CA.
FROM Jul 09th 2024 TO Jul 11th 2024
Visit Exosens at SEMICON West 2024 from July 9 to 11 in San Francisco.
Press release
Jun 14th 2024
17th-21st june 2024 - Eurosatory, parc des expositions paris-nord villepinte - hall 6 stand k51
Financial press release
Jun 12th 2024
Exosens S.A. (Compartment A, ISIN code FR001400Q9V2, ticker symbol « EXENS »), a high-tech company focused on providing mission and performance-critical amplification, detection...
Financial press release
Jun 07th 2024
In light of strong demand from investors in the placement, Exosens today announces that it increases the size of the Offering in the context of its initial public offering to 350 million euros...
Financial press release
Jun 05th 2024
In light of strong demand from investors in the placement, Exosens today announces that it increases the size of the Offering in the context of its initial public offering to 350 million euros...
Financial press release
Jun 03rd 2024
Exosens launches today its initial public offering on Euronext Paris through a private placement. The main purpose of the IPO is to enable the Group to reduce its debt in order to increase its financial flexibility...